DAN

Dana Incorporated
$34.16
+0.30 (+0.89%)
Mkt Cap 4.26B
Volume 427,109
52W Range 15.31-39.56
Sector Consumer Cyclical
Beta 1.96
EPS (TTM) -1.36
P/E Ratio 38.91
Revenue (TTM) (484.00M)
Rev Growth (5Y) +1.1%
EPS Growth (5Y) -19.2%
AlphaVal · Fair Value
$26.46
Overvalued · Moderate
29.1% above fair value
AlphaQuality · Grade · Gated
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 7.50B 10.28B 10.55B 10.16B 8.95B 7.11B 8.62B 8.14B 7.21B 5.83B 6.06B 6.62B
Net Income 85.00M (57.00M) 38.00M (242.00M) 197.00M (31.00M) 226.00M 427.00M 111.00M 640.00M 159.00M 319.00M
EPS 0.64 -0.39 0.26 -1.69 1.36 -0.21 1.57 2.94 0.72 4.38 1.00 1.97
Free Cash Flow 298.00M 70.00M (25.00M) 209.00M (211.00M) 60.00M 211.00M 243.00M 161.00M 62.00M N/A N/A
FCF / Share 2.14 0.48 -0.17 1.46 -1.46 0.42 1.47 1.68 1.11 0.42 N/A N/A
Operating CF 512.00M 450.00M 476.00M 649.00M 158.00M 386.00M 637.00M 568.00M 554.00M 384.00M N/A N/A
Total Assets 7.81B 7.49B 7.96B 7.45B 7.63B 7.38B 7.22B 5.92B 5.64B 4.86B N/A N/A
Total Debt 3.52B 2.91B 2.98B 2.72B 2.67B 2.65B 2.55B 1.78B 1.80B 1.66B N/A N/A
Cash & Equiv 476.00M 494.00M 529.00M 425.00M 268.00M 559.00M 508.00M 510.00M 603.00M 707.00M N/A N/A
Book Value 861.00M 1.33B 1.57B 1.55B 1.92B 1.76B 1.87B 1.34B 1.01B 1.16B N/A N/A
Return on Equity 0.10 -0.04 0.02 -0.16 0.10 -0.02 0.12 0.32 0.11 0.55 N/A N/A
DAN News
Dana Inc (DAN) Shares Fall 3.4% -- What GF Score of 63 Tells Investors
May 19, 2026 03:59 PM · gurufocus.com
Arianne Phosphate Successfully Produces Phosphoric Acid on a Continuous Basis
May 14, 2026 03:00 AM · globenewswire.com
Dana Incorporated (DAN) Q1 2026 Earnings Call Transcript
Apr 29, 2026 01:01 PM · seekingalpha.com
Dana Incorporated Reports Strong First-Quarter Results; Maintains Full-Year Guidance; Announces New Business Win
Apr 29, 2026 02:59 AM · prnewswire.com
Dana to Pay Dividend on Common Stock
Apr 21, 2026 12:30 PM · prnewswire.com
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics' RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Apr 20, 2026 04:15 AM · businesswire.com
Dana Inc (DAN) Stock Down 3.4% but Still Overvalued -- GF Score: 64/100
Apr 15, 2026 03:03 PM · gurufocus.com
Dana Incorporated to Announce 2026 First-quarter Financial Results, Host Conference Call and Webcast on Apr. 29
Apr 14, 2026 09:00 AM · prnewswire.com
5 Value Stocks to Buy Amid Geopolitical and Fed Uncertainty
Apr 09, 2026 06:12 AM · zacks.com
Dana (NYSE:DAN) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened
Apr 06, 2026 11:20 PM · defenseworld.net